Redirect Notice
 The previous page is sending you to https://www.brighamhealthonamission.org/2022/03/08/no-increased-risk-of-vte-with-tofacitinib-vs-tnf-inhibitors-in-routine-care/.

 If you do not want to visit that page, you can return to the previous page.